Feedback / Questions
fesomersen (IONIS-FXI-LRx) - Ionis, Bayer
Fesomersen: Data from P2b trial for thrombosis in H2 2022
(Ionis Pharmaceuticals)
-
Feb 25, 2022 -
FY 2021 Results
P2b data
•
Thrombosis
https://ir.ionispharma.com/static-files/8ba97fc2-fccf-4208-9e76-9e5d875f17ee
Feb 25, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious